Ecor1 Capital Fund, L.p. - Net Worth and Insider Trading

Ecor1 Capital Fund, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ecor1 Capital Fund, L.p. owns 4 companies in total, including Panacea Acquisition Corp (PANA.U) , Genvec Inc (GNVC) , and Nuvation Bio Inc (NUVB) among others .

Click here to see the complete history of Ecor1 Capital Fund, L.p.’s form 4 insider trades.

Insider Ownership Summary of Ecor1 Capital Fund, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
PANA.U	Panacea Acquisition Corp	2020-07-06	director & 10 percent owner
GNVC	Genvec Inc	2014-05-22	other: See Explanation of Responses
NUVB	Nuvation Bio Inc	2023-02-19	director
		2023-04-28	director & 10 percent owner

Ecor1 Capital Fund, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ecor1 Capital Fund, L.p. Ownership Network

Ownership Network List of Ecor1 Capital Fund, L.p.

No Data

Ownership Network Relation of Ecor1 Capital Fund, L.p.

Ecor1 Capital Fund, L.p. Owned Company Details

What does Panacea Acquisition Corp do?

Who are the key executives at Panacea Acquisition Corp?

Ecor1 Capital Fund, L.p. is the director & 10 percent owner of Panacea Acquisition Corp. Other key executives at Panacea Acquisition Corp include director & 10 percent owner Ecor1 Capital Fund Qualified, L.p. , director & 10 percent owner Ecor1 Capital, Llc , and director & CEO and Chairman of the Board Oleg Nodelman .

Panacea Acquisition Corp (PANA.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Panacea Acquisition Corp (PANA.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Panacea Acquisition Corp (PANA.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Panacea Acquisition Corp (PANA.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Panacea Acquisition Corp Insider Transactions

No Available Data

What does Genvec Inc do?

Who are the key executives at Genvec Inc?

Ecor1 Capital Fund, L.p. is the other: See Explanation of Responses of Genvec Inc. Other key executives at Genvec Inc include director & President and CEO Douglas J Swirsky , 10 percent owner Mmcap International Inc. Spc , and other: See Explanation of Responses Ecor1 Capital Fund Qualified, L.p. .

Genvec Inc (GNVC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genvec Inc (GNVC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genvec Inc (GNVC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genvec Inc (GNVC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genvec Inc Insider Transactions

No Available Data

What does Nuvation Bio Inc do?

Who are the key executives at Nuvation Bio Inc?

Ecor1 Capital Fund, L.p. is the director of Nuvation Bio Inc. Other key executives at Nuvation Bio Inc include Chief Medical Officer Dongfang Liu , 10 percent owner Omega Fund V Gp, L.p. , and 10 percent owner Omega Fund Iv Gp, L.p. .

Nuvation Bio Inc (NUVB) Insider Trades Summary

Over the past 18 months, Ecor1 Capital Fund, L.p. made no insider transaction in Nuvation Bio Inc (NUVB). Other recent insider transactions involving Nuvation Bio Inc (NUVB) include a net purchase of 777,895 shares made by Xiangmin Cui , a net purchase of 5,313,100 shares made by Oleg Nodelman , and a net purchase of 172,189 shares made by Kim D Blickenstaff .

In summary, during the past 3 months, insiders sold 0 shares of Nuvation Bio Inc (NUVB) in total and bought 100,000 shares, with a net purchase of 100,000 shares. During the past 18 months, 0 shares of Nuvation Bio Inc (NUVB) were sold and 6,363,184 shares were bought by its insiders, resulting in a net purchase of 6,363,184 shares.

Nuvation Bio Inc (NUVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nuvation Bio Inc Insider Transactions

No Available Data

What does Panacea Acquisition Corp II do?

Who are the key executives at Panacea Acquisition Corp II?

Ecor1 Capital Fund, L.p. is the director & 10 percent owner of Panacea Acquisition Corp II. Other key executives at Panacea Acquisition Corp II include director & 10 percent owner Ecor1 Capital Fund Qualified, L.p. , director & 10 percent owner Ecor1 Capital, Llc , and director & 10 percent owner Oleg Nodelman .

Panacea Acquisition Corp II (PANA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Panacea Acquisition Corp II (PANA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Panacea Acquisition Corp II (PANA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Panacea Acquisition Corp II (PANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Panacea Acquisition Corp II Insider Transactions

No Available Data

Ecor1 Capital Fund, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Ecor1 Capital Fund, L.p.. You might contact Ecor1 Capital Fund, L.p. via mailing address: 357 Tehama Street #3, San Francisco Ca 94103.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.